Drug CategoryDrugIHD Dosing

Administration Timing Around HD Session

AntiviralsAmantadine100mg PO Q7daysAdminister Anytime During HD

Molecular Weight    (Da)

Excreted Unchanged (%)Normal Half-Life (Hours)ESRD Half-Life (Hours)Plasma Protein Binding (%)Volume of Distribution (L/kg)Dialytic Plasma Clearance (ml/min)% Dialyzed
1519012500603-8672-5 (low flux)


  • Aronoff GR, Bennett WM, Berns JS, Brier ME, Kasbekar N, Mueller BA, et al. Drug Prescribing in Renal Failure. Philadelphia: American College of Physicians;2007.
  • DrugBank [Online]. 2012 Apr 12 [cited 2012 May 6]; Available from: URL:
  • Horadam V, Sharp J, Smilack J et al. Pharmacokinetics of amantadine hydrochloride in subjects with normal and impaired renal function. Annals of internal medicine 1981; 94(4 pt 1), 454-8.
  • Ing T, Mahurkar S, Dunea G, Hayashi J, Klawans H, Markey W. Removal of amantadine hydrochloride by dialysis in patients with renal insufficiency. Canadian Medical Association journal 1976; 115(6), 515.
  • Soung L, Ing T, Daugiradas J et al. Amantadine Hydrochloride Pharmacokinetics in Hemodialysis Patients. Annals of internal medicine 1980; 93(Part 1), 46-49.